Europe Lung Cancer Screening Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 – Regional Analysis – by Cancer Type [Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer], Technology [Low-Dose Computed Tomography (LDCT), Chest X-Ray, Liquid Biopsy, and Others], Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)

No. of Pages: 131    |    Report Code: BMIRE00029047    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Lung Cancer Screening Market

1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Lung Cancer Screening Market – by Technology

1.3.2        Europe Lung Cancer Screening Market – by Cancer Type

1.3.3        Europe Lung Cancer Screening Market – by Age Group

1.3.4        Europe Lung Cancer Screening Market – by End User

1.3.5        Europe Lung Cancer Screening Market – by Country

2.           Europe Lung Cancer Screening Market –  Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Lung Cancer Screening Market – Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Expert’s Opinion

5.           Europe Lung Cancer Screening Market –  Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Lung Cancer Incidences

5.2         Market Restraints

5.2.1        High Cost of Lung Cancer Screening Tests

5.3         Market Opportunities

5.3.1        Structured Lung Cancer Screening Program

5.4         Future Trends

5.4.1        Mobile Lung Cancer Screening Truck

5.5         Impact Analysis

6.           Europe Lung Cancer Screening Market – Europe Analysis

6.1         Europe Lung Cancer Screening Market Revenue Forecast and Analysis

7.           Europe Lung Cancer Screening Market – Revenue and Forecast to 2028 – By Cancer Type

7.1         Overview

7.2         Europe Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)

7.3         Non–Small Cell Lung Cancer (NSCLC)

7.3.1        Overview

7.3.2        Non–Small Cell Lung Cancer (NSCLC): Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Mn)

7.4         Small Cell Lung Cancer

7.4.1        Overview

7.4.2        Small Cell Lung Cancer: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

8.           Europe Lung Cancer Screening Market Analysis –  by Technology

8.1         Overview

8.2         Low-Dose Computed Tomography (LDCT)

8.2.1        Overview

8.2.2        Low-Dose Computed Tomography (LDCT): Europe Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

8.3         Chest X-ray

8.3.1        Overview

8.3.2        Chest X-ray: Europe Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

8.4         Liquid Biopsy

8.4.1        Overview

8.4.2        Liquid Biopsy: Europe Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Europe Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

9.           Europe Lung Cancer Screening Market Analysis – by Age Group

9.1         Overview

9.2 & Older

9.2.1        Overview

9.2.2 & Older: Australia Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

9.3         Below 50

9.3.1        Overview

9.3.2        Below 50: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

10.        Europe Lung Cancer Screening Market Analysis –  by End User

10.1      Overview

10.2      Hospitals

10.2.1     Overview

10.2.2     Hospitals: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

10.3      Diagnostic Centers

10.3.1     Overview

10.3.2     Diagnostic Centers: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

10.4      Others

10.4.1     Overview

10.4.2     Others: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

11.        Europe Lung Cancer Screening Market – Revenue and Forecast to 2028 – Country Analysis

11.1      Europe: Europe Lung Cancer Screening Market Overview

11.1.1.1       Germany: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.1.1       Overview

11.1.1.1.2       Germany: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.1.3       Germany: Europe Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.1.4       Germany: Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

11.1.1.1.5       Germany: Europe Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.1.6       Germany: Europe Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

11.1.1.2       UK: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.2.1       Overview

11.1.1.2.2       UK: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.2.3       UK: Europe Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.2.4       UK: Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

11.1.1.2.5       UK: Europe Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.2.6       UK: Europe Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

11.1.1.3       France: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.3.1       Overview

11.1.1.3.2       France: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.3.3       France: Europe Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.3.4       France: Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

11.1.1.3.5       France: Europe Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.3.6       France: Europe Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

11.1.1.4       Italy: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.4.1       Overview

11.1.1.4.2       Italy: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.4.3       Italy: Europe Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.4.4       Italy: Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

11.1.1.4.5       Italy: Europe Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.4.6       Italy: Europe Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

11.1.1.5       Spain: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.5.1       Overview

11.1.1.5.2       Spain: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.5.3       Spain: Europe Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.5.4       Spain: Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

11.1.1.5.5       Spain: Europe Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.5.6       Spain: Europe Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

11.1.1.6       Rest of Europe: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.6.1       Overview

11.1.1.6.2       Rest of Europe: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.6.3       Rest of Europe: Europe Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.6.4       Rest of Europe: Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

11.1.1.6.5       Rest of Europe: Europe Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.6.6       Rest of Europe: Europe Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

12.        Europe Lung Cancer Screening Market–Industry Landscape

12.1      Recent Growth Strategies

12.1.1     Overview

13.        Company Profiles

13.1      Intelerad Medical Systems

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Nuance Communications Inc

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      GE HealthCare

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Medtronic

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Canon Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Koninklijke Philips NV

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Siemens AG

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             Germany Europe Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)

Table 2.             Germany Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 3.             Germany Europe Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 4.             Germany Europe Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 5.             UK Europe Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)

Table 6.             UK Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 7.             UK Europe Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 8.             UK Europe Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 9.             France Europe Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)

Table 10.          France Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 11.          France Europe Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 12.          France Europe Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 13.          Italy Europe Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)

Table 14.          Italy Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 15.          Italy Europe Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 16.          Italy Europe Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 17.          Spain Europe Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)

Table 18.          Spain Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 19.          Spain Europe Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 20.          Spain Europe Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 21.          Rest of Europe Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)

Table 22.          Rest of Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 23.          Rest of Europe Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 24.          Rest of Europe Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 25.          Recent Growth Strategies in the Europe Lung Cancer Screening Market

Table 26.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           Europe Lung Cancer Screening Market Segmentation

Figure 2.           Europe Lung Cancer Screening Market, by Country

Figure 3.           Europe Lung Cancer Screening Market Overview

Figure 4.           Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in Europe Lung Cancer Screening Market

Figure 5.           Asia Pacific Expected to Show Remarkable Growth During Forecast Period

Figure 6.           Europe: PEST Analysis

Figure 7.           Experts’ Opinion

Figure 8.           Europe Lung Cancer Screening Market Impact Analysis of Driver and Restraints

Figure 9.           Europe Lung Cancer Screening Market – Revenue Forecast and Analysis – 2020-2030

Figure 10.        Europe Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)

Figure 11.        Non–Small Cell Lung Cancer (NSCLC): Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12.        Small Cell Lung Cancer: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 13.        Europe Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)

Figure 14.        Low-Dose Computed Tomography (LDCT): Europe Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 15.        Chest X-ray: Europe Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 16.        Liquid Biopsy: Europe Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 17.        Others: Europe Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 18.        Europe Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)

Figure 19. & Older: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 20.        Below 50: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21.        Europe Lung Cancer Screening Market, by End User, 2022 & 2030 (%)

Figure 22.        Hospitals: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 23.        Diagnostic Centers: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 24.        Others: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 25.        Europe Lung Cancer Screening Market, by Key Country – Revenue (2022) (US$ Million)

Figure 26.        Europe Lung Cancer Screening Market Revenue Share, by Country, (2022 & 2030)

Figure 27.        Germany: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 28.        UK: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 29.        France: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 30.        Italy: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 31.        Spain: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 32.        Rest of Europe: Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

The List of Companies - Europe Lung Cancer Screening Market

  1. Nuance Communications Inc
  2. GE HealthCare Technologies Inc
  3. Medtronic Plc
  4. Canon Medical Systems Corp
  5. Koninklijke Philips NV
  6. Siemens AG